Results 101 to 110 of about 1,072 (146)

Development of new strategies for the treatment of emerging opportunistic fungal infections [PDF]

open access: yes, 2016
Aspergillus fumigatus és el fong filamentós més freqüent i, encara que normalment és sensible als antifúngics, recentment s’han detectat aïllats resistents.
Martín Vicente, Adela
core   +2 more sources

Detection of the ‘Big Five’ mold killers of humans: Aspergillus, Fusarium, Lomentospora, Scedosporium and Mucormycetes [PDF]

open access: yes, 2019
This is the author accepted manuscript. The final version is available from Elsevier via the DOI in this recordFungi are an important but frequently overlooked cause of morbidity and mortality in humans. Life-threatening fungal infections mainly occur in
Thornton, CR
core   +1 more source

Identificación de hongos filamentosos y levaduras de interés clínico mediante espectrometría de masas MALDI -TOF [PDF]

open access: yes, 2022
Los hongos con relevancia clínica suponen aproximadamente el 0,04% de las especies fúngicas conocidas. Sin embargo, las infecciones fúngicas, que están asociadas a una elevada morbilidad y mortalidad, se han incrementado en las últimas décadas.
Zvezdanova, Margarita Estreya Nikolaeva
core   +1 more source

Talaromyces, Scedosporium Apiospermum, Lomentospora Prolificans, Dan Fusarium Yang Diisolasi Dari Tanah [PDF]

open access: yes, 2018
Penelitian ini bertujuan untuk mengisolasi jamur Talaromyces, Fusarium, Scedosporium apiospermum, dan Lomentospora prolificans dari tanah. Pada penelitian ini tanah yang di pakai berasal dari tanah humus yang dijual untuk tanaman hias dan tanah yang ...
Imkotta, Alberto Hendrik
core  

Identificación de los antígenos reconocidos por sueros humanos sanos en hifas de hongos del grupo Scedosporium/Lomentospora [PDF]

open access: yes, 2016
La importancia que están tomando las especies emergentes de hongos patógenos L. prolificans, S. apiospermumy S.aurantiacum, junto con el alto grado de virulencia que presentan, hace imprescindible un estudio exhaustivo de
Ugarte Lucas, Paula
core  

Hope on the horizon: Novel fungal treatments in development [PDF]

open access: yes, 2020
The treatment of invasive fungal infections remains challenging due to limitations in currently available antifungal therapies including toxicity, interactions, restricted routes of administration, and drug resistance.
Coler-Reilly, Ariella   +3 more
core   +1 more source

Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study

open access: yes
BackgroundOnly a small number of antifungal therapies for invasive fungal disease (IFD) are currently available, and many pathogens are resistant to one or more of these therapies. Olorofim, the first orotomide antifungal agent to be developed, is active
Aguado, Jose Maria   +53 more
core   +2 more sources

Síntesis y caracterización de una serie de α- aminofosfonatos y una serie de ácidos α-aminofosfínicos y evaluación in vitro de su actividad antifúngica. [PDF]

open access: yes, 2018
Propósito y método de estudio: La multiresistencia ante fármacos antifúngicos ya comercializados de Lomentospora prolificans (L. Prolificans) y algunas cepas de Candida, su carácter patogénico en los seres humanos y su capacidad invasiva en tejidos ...
Cordero Díaz, Anthonny
core  

Developing novel approaches to treat trauma - associated fungal infections [PDF]

open access: yes, 2019
Traumatic injuries often result in infections leading to high morbidity and mortality. Fungal spores, the point of interest of this research, of species such as Mucormycetes, Scedosporium, Lomentospora, Fusarium and Candida, are ubiquitous in the ...
Trzaska, Wioleta Jolanta
core  

A Lateral-Flow Device for the Rapid Detection of Scedosporium Species [PDF]

open access: yes
This is the final version. Available on open access from MDPI via the DOI in this recordData Availability Statement: The data presented in this study are available on request from the corresponding author but are not publicly available due to commercial ...
Davies, GE, Thornton, CR
core   +1 more source

Home - About - Disclaimer - Privacy